PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Jun-2021 Lennham Pharmaceuticals Announces Topline Results from Pharmacokinetic Study of d9-Caffeine Versus Caffeine Businesswire
07-Jun-2021 MyMD Pharmaceuticals Set to Join Russell Microcap® Index Businesswire
07-Jun-2021 The Scottish Medicines Consortium (SMC) Accepts Kyowa Kirin’s POTELIGEO® (mogamulizumab) for the Treatment of Those Living With Certain Ultra-rare Blood Cancers Businesswire
07-Jun-2021 Mirum Pharmaceuticals Appoints Veteran Biotechnology Executive Carol L. Brosgart, M.D. to Board of Directors Businesswire
07-Jun-2021 Humanigen Announces Ken Trbovich Appointed as Senior Vice President, Investor Relations Businesswire
07-Jun-2021 Exelixis and Ipsen Announce Detailed Results from Phase 3 COSMIC-311 Pivotal Trial of Cabozantinib in Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Presented at ASCO 2021 Businesswire
07-Jun-2021 Exelixis and Ipsen Announce Detailed Results from Phase 3 COSMIC-311 Pivotal Trial of Cabozantinib in Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Presented at ASCO 2021 Businesswire
07-Jun-2021 Charles River Laboratories Announces Long-Term Solar Contract for North American Operations Businesswire
07-Jun-2021 Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel Businesswire
07-Jun-2021 Melior Pharmaceuticals Announces Entry Into “Letter-of-Intent” for the Acquisition of Armesocarb by Adhera Therapeutics Businesswire
07-Jun-2021 Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance) Businesswire
07-Jun-2021 Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA for Migraines and Cluster Headaches Businesswire
07-Jun-2021 Exelixis et Ipsen présentent lors de la réunion de l’ASCO 2021 les résultats détaillés de l’étude de Phase III évaluant le cabozantinib chez des patients atteints d’un cancer de la thyroïde différencié Businesswire
07-Jun-2021 Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents Businesswire
07-Jun-2021 Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union Businesswire
07-Jun-2021 Reven Announces New Chief Operating Officer Businesswire
07-Jun-2021 DTx Pharma Appoints Jill Howe as Chief Financial Officer Businesswire
07-Jun-2021 New Data on KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus Sunitinib in First-Line Treatment for Patients With Advanced Renal Cell Carcinoma From Pivotal Phase 3 CLEAR/KEYNOTE-581 Trial Presented at 2021 ASCO Annual Meeting Businesswire
07-Jun-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
05-Jun-2021 KalVista Pharmaceuticals Presents Phase 2 Clinical Data of Oral KVD900 for Treatment of HAE at C1-Inhibitor Deficiency & Angioedema Workshop Businesswire